ModelEdge

Vyne Therapeutics Inc.

Filing Type	8-K
Filing Date	7/27/2026
Updated	7/29/26, 4:12 AM

Filing

Earnings Release

Exhibits

8-KMaterial Contracts, Completing Asset Acquisition or Sale, Financial Results, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Amendment to Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethi

EX-3.1EXHIBIT 3.1

EX-3.2EXHIBIT 3.2

EX-3.3EXHIBIT 3.3

EX-3.4EXHIBIT 3.4

EX-3.5EXHIBIT 3.5

EX-4.1EXHIBIT 4.1

EX-10.5EXHIBIT 10.5

EX-10.6EXHIBIT 10.6

EX-10.7EXHIBIT 10.7

EX-10.8EXHIBIT 10.8

EX-14.1EXHIBIT 14.1

EX-99.1Material Contracts, Completing Asset Acquisition or Sale, Financial Results, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Amendment to Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethi

EX-99.2Material Contracts, Completing Asset Acquisition or Sale, Financial Results, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Amendment to Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethi